University of Dundee

all News

March 2016

  • 07 Mar 2016

    Pioneering chemical technology developed at the University of Dundee is giving scientists the clearest insight yet into crucial biochemical processes that are active in many diseases, including Parkinson’s disease.   Dr Satpal Virdee, leader of the research team, said their findings could `revolutionise’ research capability.   Already the Dundee team have used their newly developed tools to make new discoveries relating to the activity of the Parkin enzyme, which when mutated is a cause of Parkinson’s disease.

  • 07 Mar 2016

    The Royal Society of Edinburgh has announced today that four people from the University of Dundee have been elected as Fellows of the RSE, three of whom are from the Schools of Life Sciences.   The new Fellows from the University are:   ·         Wendy Alexander, Vice-Principal (International) ·         Paul Birch, Professor of Plant Pathology and Deputy Head of the Division of Plant Sciences

February 2016

  • 10 Feb 2016

    A Japanese delegation visite the Wellcome Trust Building at the University of Dundee to initiate a partnership seeking to develop new treatments for inflammatory diseases.   Scientists and executives from Ono, Japan’s oldest pharmaceutical company, met with Professor Sir Philip Cohen and leading researchers from the University’s School of Life Sciences to mark the start of the collaboration, which will see the Dundee team help Ono to launch a new drug discovery project.  

  • 04 Feb 2016

    Scientists at the University of Dundee have discovered that “molecular scissors” that repair damaged and abnormal DNA are critical for keeping cancers at bay.   The laboratory of Professor John Rouse at the University’s Medical Research Council Protein Phosphorylation and Ubiquitlation Unit (MRC-PPU) first discovered that a protein called FAN1 was important for cutting and repairing damaged DNA in our cells in 2010.  

  • 04 Feb 2016

    A University of Dundee researcher has been awarded a prestigious €2million grant to investigate how DNA becomes damaged, leading to ageing and disease.   Dr Helen Walden, of the University’s School of Life Sciences, has been awarded the European Research Council (ERC) Consolidator Grant. The highly competitive awards are given to the best and most creative researchers working in Europe.  

January 2016

  • 28 Jan 2016

    International Consortium Identifies and Validates Cellular Role of Priority Parkinson’s Disease Drug Target, LRRK2 Kinase   An international public-private consortium of researchers brought together by the University of Dundee and led by The Michael J. Fox Foundation for Parkinson’s Research has identified and validated for the first time the cellular role of a primary Parkinson’s disease drug target.  

December 2015

  • 08 Dec 2015

    Yogesh Kulathu awarded €1.5 million ERC Starting Grant Dr. Yogesh Kulathu has been awarded an ERC Starting Grant of €1.5 million which will allow him to initiate an ambitious new project to understand how T-cell biology is regulated by the ubiquitin system. 

November 2015

  • 11 Nov 2015

    The MRC Protein Phosphorylation and Ubiquitylation Unit (MRC PPU) is pleased to share a new video that describes one of the most significant components of the research carried out in the Unit – communication between cells.   Entitled ‘The Heart of Research and Discovery’ and narrated by the stage and film actor Brian Cox, the animation conveys the significance of signalling events and explains how this is mediated by phosphorylation.

August 2015

  • 12 Aug 2015

    A stage-by-stage picture of a key cellular mechanism associated with the development of Parkinson’s Disease has been captured for the first time by a research team led by the University of Dundee.    The findings give further understanding of the possible causes of Parkinson’s disease and offer potential for multiple targets for therapeutics to be developed.   

June 2015